 | • レポートコード：PMR2008011 • 出版社/出版日：Persistence Market Research / 2020年5月20日 • レポート形態：英文、PDF、300ページ • 納品方法：Eメール • 産業分類：消費財 |
| Individual User（1名用） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、OTCペット薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、需要分析、価格分析、市場背景、用途別（ノミ・ダニ、鎮痛・関節炎、駆虫剤、その他）分析、ペット別（犬、猫、鳥、魚・爬虫類、その他）分析、フォーム別（チュアブル・タブレット、カプセル・軟膏、スプレー、その他）分析、販売経路別（ペット専門店、獣医クリニック、ドラッグ＆薬局、オンライン小売、その他）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・需要分析 ・価格分析 ・市場背景 ・OTCペット薬の世界市場規模：用途別（ノミ・ダニ、鎮痛・関節炎、駆虫剤、その他） ・OTCペット薬の世界市場規模：ペット別（犬、猫、鳥、魚・爬虫類、その他） ・OTCペット薬の世界市場規模：フォーム別（チュアブル・タブレット、カプセル・軟膏、スプレー、その他） ・OTCペット薬の世界市場規模：販売経路別（ペット専門店、獣医クリニック、ドラッグ＆薬局、オンライン小売、その他） ・OTCペット薬の世界市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
OTC Pet Medication Market – Scope of the Report
Persistence Market Research (PMR) recently published a new report on the OTC pet medication market for the assessment period of 2020-2030. The report offers a close look at the evolving aspects of the OTC pet medication market, and insights into the dynamics impacting market growth. It also focuses on key developments in the OTC pet medication market. The report includes various macro- and micro-economic factors responsible for having a significant impact on the OTC pet medication market.
The report on the OTC pet medication market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis on OTC pet medication underlines untapped corners for aspiring players. The report on the OTC pet medication market also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.
All the stakeholders in the OTC pet medication market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in the OTC pet medication market.
The report elaborates on both, historical and current trends shaping the market. The performance journey of the OTC pet medication market been drawn and analyzed to make lucrative opportunities in the market evident to readers. The competitive landscape presented in the OTC pet medication market report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.
The OTC pet medication market research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Boehringer Ingelheim Animal Health, Ceva Sante Animale, Bayer Companion Animal, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Elanco, and others.
OTC Pet Medication Market: Key Questions Answered in the Report
The research study on the OTC pet medication market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the OTC pet medication market report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.
How is the rapidly changing business environment impacting the growth of the OTC pet medication market?
What are the key trends that are constantly shaping the growth of the OTC pet medication market?
Which are the prominent regions that offer plentiful opportunities for players in the OTC pet medication market?
What are the differential strategies adopted by key players to hold a significant share in the global OTC pet medication market?
OTC Pet Medication Market: Research Methodology
A unique and promising research methodology forms the base of the OTC pet medication market report for the forecast period. This report has been prepared after a comprehensive analysis of market events, and riveting insights have been compiled meticulously. The research methodology for the OTC pet medication market report is a two-step process, comprising primary and secondary research. Key stakeholders such as suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Key Statistics
1.3. Summary of Key Findings
1.4. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Scope
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Trends in Major Countries
4. Global OTC Pet Medication Market Demand Analysis 2015-2019 and Forecast, 2020-2030
4.1. Historical Market Volume (‘000 Kgs) Analysis, 2015-2019
4.2. Current and Future Market Volume (‘000 Kgs) Projections, 2020-2030
4.3. Y-o-Y Growth Trend Analysis
5. Global OTC Pet Medication Market – Pricing Analysis
5.1. Pricing Analysis By Application
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor/ Retailer Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global OTC Pet Medication Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Pet Care Industry Outlook
7.1.3. Global Pet Expenditure Industry Overview
7.1.4. Global Urbanization Overview
7.2. Forecast Factors – Relevance & Impact
7.2.1. Top Companies Historical Growth
7.2.2. Global Per Capita spending Overview
7.2.3. Global OTC Pet Medication Market Sales Outlook
7.2.4. Global Pet Medical Market Growth Outlook
7.2.5. E-Commerce Sales Outlook
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030, by Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2015-2019
8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2020-2030
8.3.1. Flea & Tick
8.3.2. Pain Relief & Arthritis
8.3.3. Dewormer
8.3.4. Others
8.4. Market Attractiveness Analysis By Application
9. Global OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030, by Pet
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Pet, 2015-2019
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Pet, 2020-2030
9.3.1. Dogs
9.3.2. Cats
9.3.3. Birds
9.3.4. Fish and Reptiles
9.3.5. Small Pets
9.3.6. Others
9.4. Market Attractiveness Analysis By Pet
10. Global OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030, by Form
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Form, 2015-2019
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Form, 2020-2030
10.3.1. Chewables & Tablets
10.3.2. Capsules & Ointments
10.3.3. Sprays
10.3.4. Others
10.4. Market Attractiveness Analysis By Form
11. Global OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030, by Sales Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2015-2019
11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2020-2030
11.3.1. Pet Specialty Stores
11.3.2. Veterinary Clinics
11.3.3. Drug & Pharmacy Stores
11.3.4. Online Retail
11.3.5. Others
11.4. Market Attractiveness Analysis By Applica Sales Channel
12. Global OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) By Region, 2015-2019
12.3. Current Market Size (US$ Mn) and Forecast By Region, 2020-2030
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Application
13.3.3. By Pet
13.3.4. By Form
13.3.5. By Sales Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Application
13.4.3. By Pet
13.4.4. By Form
13.4.5. By Sales Channel
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints – Impact Analysis
14. Latin America OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Rest of Latin America
14.3.2. By Application
14.3.3. By Pet
14.3.4. By Form
14.3.5. By Sales Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Application
14.4.3. By Pet
14.4.4. By Form
14.4.5. By Sales Channel
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
15. Europe OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Application
15.3.3. By Pet
15.3.4. By Form
15.3.5. By Sales Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Application
15.4.3. By Pet
15.4.4. By Form
15.4.5. By Sales Channel
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
16. South Asia OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
16.4.1. By Country
16.4.1.1. India
16.4.1.2. Indonesia
16.4.1.3. Thailand
16.4.1.4. Rest of South Asia
16.4.2. By Application
16.4.3. By Pet
16.4.4. By Form
16.4.5. By Sales Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Application
16.5.3. By Pet
16.5.4. By Form
16.5.5. By Sales Channel
16.6. Market Trends
16.7. Key Market Participants – Intensity Mapping
16.8. Drivers and Restraints – Impact Analysis
17. East Asia OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Application
17.3.3. By Pet
17.3.4. By Form
17.3.5. By Sales Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Application
17.4.3. By Pet
17.4.4. By Form
17.4.5. By Sales Channel
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
18. Middle East and Africa (MEA) OTC Pet Medication Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. Israel
18.3.1.4. South Africa
18.3.1.5. Rest of MEA
18.3.2. By Application
18.3.3. By Pet
18.3.4. By Form
18.3.5. By Sales Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Application
18.4.3. By Pet
18.4.4. By Form
18.4.5. By Sales Channel
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints – Impact Analysis
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies (OTC Pet Medication Market)
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional Foot Print of Players
19.4.2. Product Foot Print by Players
19.4.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Bayer Companion Animal
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.2. Boehringer Ingelheim Animal Health
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.2.5.1. Marketing Strategy
20.3.2.5.2. Product Strategy
20.3.2.5.3. Channel Strategy
20.3.3. Ceva Sante Animale
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.3.5.1. Marketing Strategy
20.3.3.5.2. Product Strategy
20.3.3.5.3. Channel Strategy
20.3.4. Merck Inc.
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.4.5.1. Marketing Strategy
20.3.4.5.2. Product Strategy
20.3.4.5.3. Channel Strategy
20.3.5. Zoetis Inc.
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.5.5.1. Marketing Strategy
20.3.5.5.2. Product Strategy
20.3.5.5.3. Channel Strategy
20.3.6. Elanco
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.6.5.1. Marketing Strategy
20.3.6.5.2. Product Strategy
20.3.6.5.3. Channel Strategy
20.3.7. Virbac SA
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.7.5.1. Marketing Strategy
20.3.7.5.2. Product Strategy
20.3.7.5.3. Channel Strategy
20.3.8. Vetoquinol SA
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.8.5.1. Marketing Strategy
20.3.8.5.2. Product Strategy
20.3.8.5.3. Channel Strategy
20.3.9. Frontline
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.9.5.1. Marketing Strategy
20.3.9.5.2. Product Strategy
20.3.9.5.3. Channel Strategy
20.3.10. Zymox
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.10.5.1. Marketing Strategy
20.3.10.5.2. Product Strategy
20.3.10.5.3. Channel Strategy
20.3.11. ChloraSeb
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.11.4. Sales Footprint
20.3.11.5. Strategy Overview
20.3.11.5.1. Marketing Strategy
20.3.11.5.2. Product Strategy
20.3.11.5.3. Channel Strategy
20.3.12. Sulfox
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.12.4. Sales Footprint
20.3.12.5. Strategy Overview
20.3.12.5.1. Marketing Strategy
20.3.12.5.2. Product Strategy
20.3.12.5.3. Channel Strategy
20.3.13. Adequan
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.13.4. Sales Footprint
20.3.13.5. Strategy Overview
20.3.13.5.1. Marketing Strategy
20.3.13.5.2. Product Strategy
20.3.13.5.3. Channel Strategy
20.3.14. Dechra Pharmaceuticals PLC
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.14.4. Sales Footprint
20.3.14.5. Strategy Overview
20.3.14.5.1. Marketing Strategy
20.3.14.5.2. Product Strategy
20.3.14.5.3. Channel Strategy
20.3.15. Nutramax Laboratories, Inc.
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.15.4. Sales Footprint
20.3.15.5. Strategy Overview
20.3.15.5.1. Marketing Strategy
20.3.15.5.2. Product Strategy
20.3.15.5.3. Channel Strategy
20.3.16. Others (On Request)
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Profitability by Market Segments (Product/Channel/Packaging)
20.3.16.4. Sales Footprint
20.3.16.5. Strategy Overview
20.3.16.5.1. Marketing Strategy
20.3.16.5.2. Product Strategy
20.3.16.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
List Of Table:Table 1: Global OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 2: Global OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 3: Global OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 4: Global OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 5: Global OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 6: Global OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 7: Global OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 8: Global OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 9: Global OTC Pet Medication Market Value (US$ Mn) Forecast, By Region, 2015–2030
Table 10: Global OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Region, 2015–2030
Table 11: North America OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 12: North America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Country, 2015–2030
Table 13: North America OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 14: North America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 15: North America OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 16: North America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 17: North America OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 18: North America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 19: North America OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 20: North America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 21: Latin America OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 22: Latin America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Country, 2015–2030
Table 23: Latin America OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 24: Latin America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 25: Latin America OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 26: Latin America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 27: Latin America OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 28: Latin America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 29: Latin America OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 30: Latin America OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 31: Europe OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 32: Europe OTC Pet Medication Market Volume (US$ Mn) Forecast, By Country, 2015–2030
Table 33: Europe OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 34: Europe OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 35: Europe OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 36: Europe OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 37: Europe OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 38: Europe OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 39: Europe OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 40: Europe OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 41: South Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 42: South Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Country, 2015–2030
Table 43: South Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 44: South Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 45: South Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 46: South Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 47: South Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 48: South Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 49: South Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 50: South Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 51: East Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 52: East Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Country, 2015–2030
Table 53: East Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 54: East Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 55: East Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 56: East Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 57: East Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 58: East Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 59: East Asia OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 60: East Asia OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 61: Oceania OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 62: Oceania OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Country, 2015–2030
Table 63: Oceania OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 64: Oceania OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 65: Oceania OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 66: Oceania OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 67: Oceania OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 68: Oceania OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 69: Oceania OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 70: Oceania OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030
Table 71: Middle East and Africa OTC Pet Medication Market Value (US$ Mn) Forecast, By Country, 2015–2030
Table 72: Middle East and Africa OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Country, 2015–2030
Table 73: Middle East and Africa OTC Pet Medication Market Value (US$ Mn) Forecast, By Application, 2015–2030
Table 74: Middle East and Africa OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Application, 2015–2030
Table 75: Middle East and Africa OTC Pet Medication Market Value (US$ Mn) Forecast, By Form, 2015–2030
Table 76: Middle East and Africa OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Form, 2015–2030
Table 77: Middle East and Africa OTC Pet Medication Market Value (US$ Mn) Forecast, By Pet, 2015–2030
Table 78: Middle East and Africa OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Pet, 2015–2030
Table 78: Middle East and Africa OTC Pet Medication Market Value (US$ Mn) Forecast, By Sales Channel, 2015–2030
Table 79: Middle East and Africa OTC Pet Medication Market Volume (‘000 Kgs) Forecast, By Sales Channel, 2015–2030